Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Pfizer Reaches Three Settlement Agreements for VYNDAMAX

Wednesday, April 29, 2026

Pfizer Inc today announced that it has entered into settlement agreements with generic drug manufacturers Dexcel Pharma Hikma Pharmaceuticals and Cipla Ltd regarding lawsuits filed in the US District Court for the District of Delaware for infringemen...

Thermo Fisher Scientific Opens U.S. Flagship Bioprocess Design Center to Accelerate the Delivery of Life-changing Therapies

Wednesday, April 29, 2026

Thermo Fisher Scientific Inc the world leader in serving science today announced the opening of its flagship US Bioprocess Design Center BDC at the companys Plainville Mass site expanding the facility to support customers

Samsung Bioepis and ATLATL Sign Memorandum of Understanding (MoU) to Accelerate Early-Stage Biotech Innovation in Asia-Pacific

Wednesday, April 29, 2026

Samsung Bioepis Co Ltd and ATLATL Innovation Center hereinafter referred to as ATLATL global innovation platform for life science research and development today announced that the companies have entered

Xcovery Partners with EVERSANA to Commercialize Lung Cancer Drug Ensacove in the U.S.

Tuesday, April 28, 2026

Xcovery Holdings Inc Xcovery an evidencebased innovationdriven pharmaceutical company today announced an agreement with EVERSANA a leading provider of commercialization services to the global life sciences industry

Prothena Announces Novo Nordisk Obtains Fast Track Designation from the U.S. FDA for Coramitug (PRX004) in ATTR Amyloidosis with Cardiomyopathy

Tuesday, April 28, 2026

Prothena Corporation plc today announced that the US Food and Drug Administration FDA has granted Fast Track Designation to coramitug a potential bestinclass amyloid depleter antibody currently in Phase development

IMG Pharma Enters into Definitive Agreement to Acquire Matsumoto Pharmaceutical

Tuesday, April 28, 2026

IMG Pharmaceutical Co Ltd IMG Pharma a majorityowned subsidiary of IMG Japan the Groups holding company announced that it has entered into a definitive agreement to acquire Matsumoto Pharmaceutical Co Ltd a Japanese pharmaceutical manufacturer

Thermo Fisher Scientific Signs Agreement to Sell its Microbiology Business to Astorg

Tuesday, April 28, 2026

Thermo Fisher Scientific Inc NYSE TMO the world leader in serving science today announced that it has signed a definitive agreement to sell its microbiology business to Astorg a leading panEuropean private equity firm

Sun Pharma signs Definitive Agreement to Acquire Organon

Tuesday, April 28, 2026

Sun Pharmaceutical Industries Limited Reuters SUNBO Bloomberg SUNP IN NSE SUNPHARMA BSE together with its subsidiaries andor associated companies Sun Pharma and Organon Co

Mabwell Initiates Phase III Clinical Study of its Nectin-4-Targeting ADC 9MW2821 for the Treatment of Triple-Negative Breast Cancer

Friday, April 24, 2026

Mabwell an innovationdriven biopharmaceutical company with a fully integrated industry chain announces the initiation of a Phase III clinical study of its proprietary Nectintargeting ADC for the treatment of triplenegative breast cancer

WuXi Biologics Receives South Korea MFDS GMP Certification to Enable Commercial Manufacturing of Bispecific Antibody Therapeutics

Thursday, April 23, 2026

WuXi Biologics HK a leading global Contract Research Development and Manufacturing Organization CRDMO announced that three of its manufacturing facilities in Wuxi Drug Substance Facility MFG